quantity destroyed or returned to sponsor

For structured SOP templates to design such logs, see Pharma SOP documentation.

Chain of Custody and Site-Level Records:

The chain of custody ensures that IPs are handled only by authorized personnel and documents every step in the supply chain. Each site must maintain site-specific logs with clearly assigned custodianship.

Recommended Site-Level Records:

1. Site receipt log (with courier confirmation and temperature data)
2. Site storage monitoring records
3. Subject-specific dispensation logs
4. Returns and destruction logs
5. Deviation reports (e.g., missed doses, broken vials)

Subject-Level IP Tracking:

Subject accountability forms should record each instance of IP usage, return, or loss. These forms must be cross-checked with the visit schedule and Case Report Forms (CRFs).

Best Practices for Subject IP Logs:

• Record each dispensation by subject and visit
• Use barcoded labels to match kit numbers
• Maintain subject-specific logbooks or eLogs
• Document missed or refused doses with reason

IP Inventory Management Systems:

Many sponsors implement Interactive Web Response Systems (IWRS) to track IP inventory across all sites in real time. This provides centralized visibility and auto-reconciliation features.

Key Benefits of IWRS for IP Tracking:

1. Real-time inventory updates
2. Automated alerts for reordering and expiry
3. Built-in randomization and blinding integration
4. Secure audit trails

For additional control, ensure these systems are CSV validated under GxP compliance.

Temperature-Sensitive Product Tracking:

For IPs requiring cold chain storage, accountability logs must also include temperature monitoring details. Deviations must be captured along with the disposition of affected units.

Visit Stability Studies to understand excursion impact and mitigation strategies.

Required Logs for Cold Chain IPs:

• Shipment temperature data reports
• Daily storage temperature logs
• Excursion investigation reports
• Cold storage equipment calibration certificates

Reconciliation and Destruction Procedures:

At the end of a trial or site closure, reconciliation ensures that all IP dispensed is either accounted for or properly destroyed. Sponsors must ensure compliance with protocols and local regulations for disposal.

Reconciliation Steps:

1. Match quantity received vs. dispensed vs. returned
2. Account for all discrepancies with deviation reports
3. Obtain written authorization before destruction
4. Use licensed vendors for destruction of drug product
5. Archive destruction certificates and reconciliation summary

Audit Readiness and Regulatory Compliance:

Agencies like MHRA and CDSCO require access to site accountability logs during audits and inspections. Records must be legible, verifiable, and contemporaneous.

Compliance Checklist:

• Logs filled in ink or electronically with audit trails
• No overwriting or retrospective entries
• Timely updates after each subject visit
• Documented staff training on accountability procedures

Training and Quality Oversight:

Site and sponsor personnel must be trained on IP tracking SOPs. Regular monitoring and internal audits ensure adherence to documented procedures and immediate identification of gaps.

Key Training Topics:

• Accountability log formats and requirements
• Chain of custody protocols
• IWRS/IP inventory system usage
• Deviation handling and reporting

Conclusion:

Maintaining accountability logs and tracking investigational products are foundational elements of successful clinical trial conduct. Whether through manual logs or digital systems, the integrity, transparency, and timeliness of these records determine regulatory compliance and patient safety. Sponsors and sites must work collaboratively to ensure robust documentation practices are implemented and maintained throughout the trial lifecycle.